Transplant Diagnostic Market Is Projected To Witness Growth Based On Rising Investment In Research & Development Till 2024:Grand View Research,inc.
The global transplant diagnostic market is expected to reach
USD 895.2 million by 2024, according to a new report by Grand View Research
Inc. The rising demand for organ transplantation is primarily fueling the
demand for transplant diagnostics.
Constant healthcare research and development efforts are
resulting in the introduction of technically advanced treatments, such as stem
cell therapy and organ transplants. As a result, the adoption of these
highly-advanced organ transplantation techniques is creating the demand for
transplant diagnostics as they reduce the risk of infections and minimize the
chances of an immune response through pre-operative assessments including
histocompatibility tests, such as Human Leukocyte Antigen (HLA) typing, which
determines donor-receiver organ or tissue compatibility prior to organ
transplants.
In addition, pertinent organizations are supporting research
and development initiatives in the field of organ transplant through grants and
funding. As a result, innovative and advanced diagnostic tools are frequently entering
into the market. On the other hand, high cost of the diagnostic tests is one of
the major factors hindering the growth of the market.
Geographically, the market has been segmented into North
America, Europe, Asia Pacific, Latin America, and Middle East and Africa (MEA).
North America and Europe together accounted for the largest market share in
2015. Developed economies and well-established healthcare infrastructure
coupled with the presence of a highly developed research infrastructure are
accelerating the adoption of organ and tissue transplant therapies in Europe
and North America. As a consequence, the demand for transplant diagnostics is
high in North America and Europe.
Wide adoption of HLA typing owing to its ability to
determine organ compatibility between the donor and the receiver preceding
organ transplants and to predict potential perioperative immunological
complications is driving the growth of the molecular assay market in North
America and Europe.
Asia Pacific is expected to show the fastest growth rate
during the forecast period owing to the booming medical tourism in countries,
such as India. Availability of advanced healthcare infrastructure and skilled
professionals at alower costare anticipated to attract patients worldwide to this
region for transplant procedures.
In addition, the presence of highly advanced healthcare
infrastructure and the ongoing government initiatives to improve healthcare
facilities in the country are collectively anticipated to boost the market
growth in Japan during the forecast period. As a result, the Asia Pacific
market is anticipated to reach USD 216.6 million in 2024.
Browse full research report on Transplant Diagnostic
Market: http://www.grandviewresearch.com/industry-analysis/transplant-diagnostic-market
Further key findings from the study suggest:
- The
PCR-based molecular assay captured the largest share of the overall market
in 2015. The large market share was mainly attributed to the extensive
adoption of the PCR technique in HLA typing.
- The
sequencing-based typing segment is anticipated to witness significant
growth rate from 2016 to 2024. The escalation in the adoption of next
generation sequencing (NGS) is the major factor expected to drive the
growth of this segment during the forecast period.
- The
integration of sequencing with serological typing enhances diagnostic
outcomes and, hence is expected to augment the growth of the sequencing
segment during the forecast period
- The
reagents and consumables segment accounted for the largest market share in
2015. This large share is mainly attributed to the repeat purchase of
these products.
- North
America captured the largest market share of around 38% in 2015 and is
expected to maintain its dominance throughout the forecast period.
Well-established research infrastructure, the increasing healthcare
expenditure, high adoption rate ofthe advanced diagnostic techniques, and
the growing R&D activities are some of the factors supporting the
growth of the market in the region.
- Asia
Pacific is expected to witness significant growth during the forecast
period owing to the expanding research opportunities, the increasing
health care expenditure, and the rising awareness of organ donation in the
region.
- The
booming medical tourism industry offers further growth opportunities for
the market in Asia Pacific
- Some
major players in this market include Thermo Fisher Scientific, Inc.,
Illumina, Inc., F.Hoffmann La-Roche AG. Abbott Laboratories, Inc.,Qiagen
N.V., Immucor Transplant Diagnostics, Inc., Bio-Rad Laboratories, Inc.,
Affymetrix, Inc., and Omixon Ltd.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/healthcare
Grand View Research has segmented the Transplant Diagnostic
Market on the basis of technology, product, and geography.
Transplant Diagnostic Market by Technology, 2013 - 2024
(USD Million)
- Molecular
Assays
- PCR-Based
Molecular Assays
- Sequencing-Based
Molecular Assays
- Non-Molecular
Assays
- Serological
Assays
- Mixed
Lymphocyte Culture (MLC) Assays
Transplant Diagnostic Market by Product, 2013 - 2024 (USD
Million)
- Reagents
and Consumables
- Instruments
- Software
and Services
Transplant Diagnostics Market, by Region, 2013- 2024 (USD
Million)
- North
America
- U.S.
Transplant Diagnostics Market by Product Type
- Canada
Transplant Diagnostics Market by Product Type
- U.S.Transplant
Diagnostics Market by Technology Type
- Canada
Transplant Diagnostics Market by Technology
- Europe
- Germany
Transplant Diagnostics Market by Product Type
- France
Transplant Diagnostics Market by Product Type
- Germany
Transplant Diagnostics Market by Technology
- France
Transplant Diagnostics Market by Technology
- Asia
Pacific
- China
Transplant Diagnostics Market by Product Type
- India
Transplant Diagnostics Market by Product Type
- China
Transplant Diagnostics Market by Technology
- India
Transplant Diagnostics Market by Technology
- Latin
America
- Brazil
Transplant Diagnostics Market by Product Type
- Mexico
Transplant Diagnostics Market by Product Type
- Brazil
Transplant Diagnostics Market by Technology
- Mexico
Transplant Diagnostics Marketby Technology
- MEA
- South
Africa Transplant Diagnostics Market by Product Type
- South
Africa Transplant Diagnostics Market by Technology
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting services.
To help clients make informed business decisions, we offer market intelligence
studies ensuring relevant and fact-based research across a range of industries,
from technology to chemicals, materials and healthcare.
Comments
Post a Comment